pcDNA-HA-ER WT Citations (8)
Originally described in: ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.Toy W, Shen Y, Won H, Green B, Sakr RA, Will M, Li Z, Gala K, Fanning S, King TA, Hudis C, Chen D, Taran T, Hortobagyi G, Greene G, Berger M, Baselga J, Chandarlapaty S Nat Genet. 2013 Dec;45(12):1439-45. doi: 10.1038/ng.2822. Epub 2013 Nov 3. PubMed Journal
Articles Citing pcDNA-HA-ER WT
| Articles |
|---|
| Estrogen receptor alpha (ESR1)-signaling regulates the expression of the taxane-response biomarker PRP4K. Lahsaee S, Corkery DP, Anthes LE, Holly A, Dellaire G. Exp Cell Res. 2016 Jan 1;340(1):125-31. doi: 10.1016/j.yexcr.2015.12.013. Epub 2015 Dec 19. PubMed |
| The mTOR inhibitor AZD8055 overcomes tamoxifen resistance in breast cancer cells by down-regulating HSPB8. Shi JJ, Chen SM, Guo CL, Li YX, Ding J, Meng LH. Acta Pharmacol Sin. 2018 Jan 18. pii: aps2017181. doi: 10.1038/aps.2017.181. PubMed |
| SMURF1 facilitates estrogen receptor a signaling in breast cancer cells. Yang H, Yu N, Xu J, Ding X, Deng W, Wu G, Li X, Hou Y, Liu Z, Zhao Y, Xue M, Yu S, Wang B, Li X, Niu G, Wang H, Zhu J, Zhuang T. J Exp Clin Cancer Res. 2018 Feb 12;37(1):24. doi: 10.1186/s13046-018-0672-z. PubMed |
| ERalpha promotes murine hematopoietic regeneration through the Ire1alpha-mediated unfolded protein response. Chapple RH, Hu T, Tseng YJ, Liu L, Kitano A, Luu V, Hoegenauer KA, Iwawaki T, Li Q, Nakada D. Elife. 2018 Feb 16;7. pii: 31159. doi: 10.7554/eLife.31159. PubMed |
| XBP1 increases transactivation of somatic mutants of ESR1 and loss of XBP1 reverses endocrine resistance conferred by gain-of-function Y537S ESR1 mutation. Barua D, Abbasi B, Gupta A, Gupta S. Heliyon. 2020 Oct 10;6(10):e05217. doi: 10.1016/j.heliyon.2020.e05217. eCollection 2020 Oct. PubMed |
| ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation. Li Z, McGinn O, Wu Y, Bahreini A, Priedigkeit NM, Ding K, Onkar S, Lampenfeld C, Sartorius CA, Miller L, Rosenzweig M, Cohen O, Wagle N, Richer JK, Muller WJ, Buluwela L, Ali S, Bruno TC, Vignali DAA, Fang Y, Zhu L, Tseng GC, Gertz J, Atkinson JM, Lee AV, Oesterreich S. Nat Commun. 2022 Apr 19;13(1):2011. doi: 10.1038/s41467-022-29498-9. PubMed |
| YAP inhibits ERalpha and ER(+) breast cancer growth by disrupting a TEAD-ERalpha signaling axis. Li X, Zhuo S, Zhuang T, Cho YS, Wu G, Liu Y, Mu K, Zhang K, Su P, Yang Y, Zhang CC, Zhu J, Jiang J. Nat Commun. 2022 Jun 2;13(1):3075. doi: 10.1038/s41467-022-30831-5. PubMed |
| Overexpression of estrogen receptor GPER1 and G1 treatment reduces SARS-CoV-2 infection in BEAS-2B bronchial cells. Costa AJ, Lemes RMR, Bartolomeo CS, Nunes TA, Pereira GC, Oliveira RB, Gomes AL, Smaili SS, Maciel RMB, Newson L, Ramirez AL, Okuda LH, Prado CM, Stilhano RS, Ureshino RP. Mol Cell Endocrinol. 2022 Dec 1;558:111775. doi: 10.1016/j.mce.2022.111775. Epub 2022 Sep 9. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.